The Committee appreciates the government’s efforts over the past two years to continue aligning the insurance industry with international standards and innovate in new areas, including e-commerce, Offshore Insurance Units (OIUs), and wealth management. We welcome these developments and look forward to supporting Taiwan to deepen and expand its financial liberalization in areas such as insurance-related products, services, foreign exchange, and digitalization.
Suggestion 1: Enable cross-border purchasing of digital insurance products.
Given the increasing market demand for digital insurance, easing identity verification procedures and related regulations has become increasingly important for delivering more robust digital insurance services. A significant step forward was the proposal to allow customers that are Taiwanese nationals residing overseas to purchase insurance products remotely through local insurers’ OIU branches by the end of 2025. The Committee looks forward to early implementation of this change, in response to strong demand from those residing, working, and studying abroad.
Suggestion 2: Adopt differentiated supervision after implementing the new generation solvency system.
The new generation solvency system, Taiwan Insurance Solvency (TIS), introduces a more risk-sensitive approach to evaluating insurers’ financial strength, defined as their ability to meet future policyholder claims. Following its implementation, the Committee recommends adopting differentiated supervision based on each life insurer’s financial position. For companies that have not applied for any TIS transitional measures and whose capital adequacy ratio, which measures how much capital an insurer holds relative to required minimum levels, is more than twice the requirement, supervision can be moderately relaxed. For these capital-adequate companies, we recommend easing certain product and investment restrictions and simplifying the review of cash dividend distributions.
2.1 Relax product approval for combined participating and non-participating health or injury insurance. Taiwan’s life insurance market has sold participating policies for more than 20 years, and the Financial Supervisory Commission (FSC) has further improved product governance through its 2024 “Directions for Life Insurance Companies Conducting Participating Insurance Business.” At the same time, traditional non-participating products, including interest-sensitive products, are already commonly combined with non-participating health or injury insurance and are subject to a file-and-use product approval process. Experience with these combined products shows that, as long as there is complete sales disclosure, customers do not misunderstand the non-guaranteed elements. We recommend allowing companies with capital adequacy ratios exceeding twice the required minimum to use a file-and-use process for participating products combined with non-participating health or injury insurance.
2.2 Simplify the cash dividend review mechanism for capital-adequate insurers. Under the Company Act and the Insurance Act, a company may distribute profits after covering losses, paying taxes, and appropriating all required legal and special reserves. The financial statements must be audited by an accountant, approved by the company’s board of directors, and then ratified by a shareholders’ meeting before cash dividends can be paid. However, FSC administrative order No. 10202501992 additionally requires life insurers to obtain prior approval from the FSC before distributing cash dividends. The FSC conducts a case‑by‑case review of the insurer’s implementation of new accounting standards, operating performance, and financial soundness. We suggest allowing companies with capital adequacy ratios exceeding twice the required minimum to distribute cash dividends in accordance with the Company Act and the Insurance Act without the need for separate prior FSC approval, due to having demonstrated sustained financial discipline and sound management performance.
2.3 Allow reserves for next-year foreign currency non-investment-linked life insurance products to be excluded from foreign investment limits to improve asset-liability matching. With the implementation of International Financial Reporting Standard 17 Insurance Contracts (IFRS 17) and the TIS, effective asset-liability management has become even more important for life insurers. For non-investment-linked policies with foreign currency receipts and payments, it would be desirable to invest 100% of the relevant reserves in foreign currency assets to achieve better matching.
Foreign life insurers in particular rely heavily on such products and therefore have a strong demand for matching foreign currency assets. However, Paragraph 2, Article 146-4 of the Insurance Act imposes foreign investment limits, including a cap on the proportion of funds that may be invested abroad, which constrain the sale of these policies and increase the difficulty of developing Taiwan as the “Asian Asset Management Center”. For insurers with sufficient capital, we therefore propose that reserves set aside for next-year sales of non-investment-linked life insurance products with foreign currency receipts and payments be excluded from the calculation of their foreign investment limits. In addition to existing transitional relief, this type of incentive-based supervisory measure rewards insurers that meet the relevant solvency and governance standards.
Suggestion 3: Build an innovation base in the local asset management zone using a “closed-loop experiment” approach.
The government is establishing Local Asset Management Zones, which prioritize the pilot implementation of international-level financial products within a limited geographical area, target specific high-net-worth clients, and employ a limited number of qualified financial institutions. The Committee supports the Local Asset Management Zone initiative and encourages the introduction of additional insurance-related pilot programs.
3.1 Introduce multi-currency conversion policies to meet dynamic asset-allocation needs. To meet the asset liquidity requirements of high-end international clients, we recommend assessing the pilot program of multi-currency conversion policies within the designated area. These products allow policyholders to freely switch the currency of an account under a single contract, depending on life stages, such as overseas study, retirement, or inheritance.
3.2 Incorporate global asset-allocation services into regulations to enhance synergies for cross-border financial groups. To meet the needs of high-net-worth clients for global asset-allocation and one-stop services, priority should be given to ensuring the legitimacy of products from foreign affiliates of local insurance companies within the designated zone. Under the regulatory framework, professional advisors should provide information sharing and administrative assistance. This step will leverage the synergies of cross-border collaboration among financial groups and prevent unscrupulous brokers from misleading policyholders into purchasing questionable products.
3.3 Relax foreign-investment limits for foreign currency products in the asset management zones to enhance fund utilization resilience. The current foreign investment limit system for the insurance industry restricts the industry’s returns and asset-allocation space. Granting exemptions within the pilot program of these zones would significantly increase the flexibility of the insurance industry’s fund utilization. To ensure the international competitiveness of foreign currency products sold within the established zones, reserves for such products should not be included in calculating foreign-investment limits under Article 146-4 of the Insurance Act.
Suggestion 4: Provide guidance on the review of premium rate and policy conditions for one-year guaranteed-renewal personal health insurance products.
Given the rapid changes in the healthcare environment, including rising medical costs, increased claim frequencies, aging populations, and the introduction of new medical technologies, the original pricing assumptions for health-insurance products risk becoming inadequate several years after launch. To ensure the sound operation of the insurance market and to maintain long-term, sustainable protection for policyholders, insurance companies should be allowed to adjust the renewal premium rates for guaranteed renewable individual health-insurance products.
On July 25, 2025, the Taiwan Insurance Institute (TII) convened a meeting of insurers to discuss revisions to the “Operating Procedures and Reporting Format for Rate Testing Standards of One-Year or Shorter Accident and Health Insurance Products” as the basis for premium adjustments to guaranteed renewable individual health-insurance products. Subsequently, TII drafted revised guidelines and added an appendix providing supplementary explanations on the review of premium rates and policy conditions for one-year guaranteed-renewal personal health-insurance products. The appendix specifies limits on premium adjustments and has been submitted to the Insurance Bureau, where it remains under regulatory review.
To enhance system transparency, ensure the reasonableness of premium adjustments, and provide a clear legal framework for industry compliance, the Committee urges the Insurance Bureau to expedite approval and promulgation of the new appendix so that insurers have a regulatory basis for adjusting renewal premium rates of guaranteed-renewable health insurance products, thereby supporting the long-term sustainability of such products.
過去兩年,台灣持續推動保險業接軌國際標準,並在電子商務、國際保險業務分公司(Offshore Insurance Units,OIU)、財富管理業務等領域持續開放創新。本委員會歡迎此一發展,並期待台灣在保險相關商品、服務、匯兌、數位化方面繼續推進金融自由化的深度與廣度,吸引國際人才與資本匯聚,讓台灣在亞太金融市場中具備更強的競爭力與影響力。
建議一:持續推進數位保險,開放本國境外客戶購買保險商品
隨著市場對數位保險(digital insurance)的需求日益增加,身分驗證程序及其他法規的持續鬆綁成為保險業提供數位保險服務的關鍵因素。2025年底研議開放本國境外客戶可透過遠距投保於境外向本國保險業OIU分公司購買保險商品,即為重要進展。本委員會建議可接續開放本國客戶於境外透過遠距投保向本國保險業購買保險商品,以回應本國客戶在全球居留、工作、學習時對保障的強烈需求。
建議二:實施新一代清償能力制度(TIS)後,應針對不同清償能力的業者採取差異化監理
我國保險業新一代清償能力制度(Taiwan Insurance Solvency,以下簡稱 TIS)強調風險敏感性,藉由評估保險業清償能力來衡量其財務健全度。實施TIS制度後,本委員會建議依壽險公司清償能力高低採取差異化監理。對於未申請任何TIS過渡措施,且在新制下資本適足率達最低資本適足要求兩倍以上之公司,可適度放寬部分監理要求,以鼓勵業者進行長期且主動的資本韌性管理,並強化臺灣壽險業整體資本水準。對於此類資本充足公司,建議在商品與投資相關規範及現金股利審查程序上給予適度鬆綁,作為對健全資本與自律經營的正向誘因。
2.1 放寬分紅保險商品結合不分紅健康或傷害保險,得採備查制送審
臺灣壽險市場自 2003 年開放分紅保險以來已發展二十餘年,金融監督管理委員會(以下簡稱金管會)並於 2024 年發布「人身保險業辦理分紅人壽保險商品業務應注意事項」,使商品規範更臻完備。同時,傳統型不分紅商品(含利率變動型)結合不分紅健康或傷害保險之設計在市場上已相當普遍,且採備查制送審;實務經驗顯示,在充分銷售揭露下,即使商品包含非保證項目,客戶亦不致產生誤解。鑑此,本委員會建議對前述資本適足率為最低資本適足要求兩倍以上之公司,將分紅保險商品結合不分紅健康或傷害保險之產品審查,同樣放寬為採備查制送審,以提供公司積極充實資本的額外誘因。
2.2 簡化資本充足壽險公司現金股利發放審查機制
依《公司法》及《保險法》的規定,保險公司於彌補虧損、繳納稅捐並提列各項法定及特別盈餘公積後,得分配盈餘;財務報表須經會計師查核,並經董事會及股東會決議後,始得發放現金股利。然而,金管會 2013 年發布之金管保財字第 10202501992 號函,要求壽險公司除符合《公司法》與《保險法》規定外,尚須事前向金管會申報,並由金管會就新會計準則導入情形、經營績效及財務健全度逐案審查,獲准後方得發放現金股利。對已符合前述資本適足率為最低資本適足要求兩倍以上之公司,因其已具長期積極的財務業務紀律及經營管理績效,本委員會建議簡化現金股利發放審查機制,回歸依《公司法》與《保險法》程序辦理,免再逐案向金管會申報核准。
2.3 允許業者次一年度所銷售外幣收付之非投資型人身保險商品準備金不計入其國外投資限額,以強化資產負債配適
隨著國際財務報導準則第17號公報「保險合約」(IFRS 17)及TIS制度實施,資產負債管理的重要性與日俱增。 對於具外幣收付之非投資型保單而言,理論上應以 100% 外幣資產支應相關準備金,方能達到較佳的資產負債配適;外商壽險公司尤為重視此一配適需求,除新臺幣商品外,對具外幣收付之非投資型保單亦有相當比重之需求。然而,受限於《保險法》第 146 條之 4 第 2 項外匯投資比率規定,此類保單銷售及資產配置受到限制,也增加推動「亞洲資產管理中心」政策的難度。本委員會建議,對符合前述資本適足條件之公司,允許業者次一年度所銷售外幣收付之非投資型人身保險商品準備金不計入其國外投資限額;在提供過渡性放寬措施之外,增加此類具誘因性的監理措施,以獎勵長期自律且資本健全之壽險公司,營造更公平合理的監理環境。
建議三:在地方資產管理專區以「封閉式實驗」建構創新基地
政府推動「地方資產管理專區」,在限定的地理區域、限定的高資產客群以及限定的合格金融機構框架下,優先試辦國際級金融商品。本委員會支持地方資產管理專區政策,並希望有更多保險面向的試辦項目。
3.1 引入「多元貨幣轉換保單」,滿足動態資產配置需求
為對接國際高端客群對資產流動性的需求,建議評估在專區內開放「多元貨幣保單」之試辦。這類商品允許保戶在單一契約下,因應人生階段(如海外留學、退休、傳承)自由轉換計價幣別。
3.2 將「全球配置推介服務」納入監管,強化跨境金融集團綜效
為滿足高資產客戶對全球資產配置及一站式服務的需求,建議在專區內優先開放「推介本地保險業之外國關係企業合法商品」,在法規框架下由專業顧問提供資訊對接及行政協助。如此能發揮金融集團跨境協作綜效,更能有效防堵不肖掮客誤導保戶購買有疑慮的商品。
3.3 放寬「專區外幣商品」國外投資限額,提升資金運用韌性
現行保險業國外投資限額制度限制保險業的收益率與資產配置空間,若能在專區試辦範圍內給予額度豁免,將能大幅提高保險業資金運用的彈性。為使專區內銷售之外幣商品具備國際競爭力,建議該類商品之準備金運用不納入《保險法》第146條之4之國外投資限額計算。
建議四:明訂「保證續保之一年期個人健康保險商品費率條款審查補充說明」以作為保證續保個人健康保險商品調整續保費率之依循
目前醫療環境快速變動,包含醫療成本上升、理賠頻率提高、人口結構老化及新型醫療技術引入等因素,皆可能使原始健康險商品費率假設在若干年後顯得不足。為維持保險市場之健全運作,並確保保險商品能長期、永續地提供客戶保障,保證續保個人健康保險商品有其調整續保費率之必要性。財團法人保險事業發展中心(以下簡稱保發中心)已於2025年7月25日邀集各保險業者研商修正「一年期以下傷害保險及健康保險商品訂價合理性作業指引」,以作為保證續保個人健康保險商品調整續保費率之依循。後續保發中心已撰寫該指引修正草案,新增附錄「保證續保之一年期個人健康保險商品費率條款審查補充說明」,規範費率調整限制,並函報保險局;目前該修正草案之附錄仍處於主管機關審核階段。故為提升制度之透明度,並確保調整費率之合理性及具備完善法令可供依循,本委員會期待保險局儘速核訂新增附錄「保證續保之一年期個人健康保險商品費率條款審查補充說明」, 提供業者調整保證續保個人保險費率之依循,以維持保單可持續經營。
